Medical Challenges for the Monarch
The Royal Palace announced that King Harald has been undergoing cortisone treatment for hemolytic anemia, a blood disorder. The treatment resulted in a fluid buildup within his body severe enough to necessitate medical supervision. While the palace did not specify a discharge date, the King has been placed on leave from official duties for two weeks. During this period, Crown Prince Haakon has stepped in as regent, a role he has previously filled during his father’s periods of ill health or absence from the country.
The King’s recent health has been a source of concern for the Norwegian public. Earlier this month, a routine visit to Rikshospitalet sparked widespread anxiety after media outlets mistakenly reported that the King had been transported by ambulance. The Royal House quickly clarified that the King was well and merely attending a scheduled health checkup. These incidents have kept the monarchy’s internal health matters in the spotlight, reinforcing the narrative that the aging King remains central to public discourse despite his advancing years.
A Personal and Constitutional Stand
King Harald’s health is not the only medical crisis currently facing the royal family. His son’s wife, Crown Princess Mette-Marit, is navigating a prolonged recovery following a lung transplant. The procedure was necessary after years of declining lung function and a diagnosis of pulmonary fibrosis. For the majority of the summer, Mette-Marit has remained out of the public eye, focusing on rebuilding her strength in peace.
Her decision to interrupt this recovery to visit the King in the hospital is a clear statement of the bond within the family. It also serves as a reminder of the resilience required of the royal household. Are Holm, Head of the Department of Respiratory Medicine at Oslo University Hospital, noted that Mette-Marit’s condition is as good as expected under the circumstances. However, he emphasized that the next six months will involve physical rehabilitation and close monitoring for potential complications, including rejection and infections. Consequently, she is not expected to carry out official engagements during this period, and Prince Haakon has scaled back his own schedule to support her recovery.
The family dynamic during this challenging time includes other notable adjustments. Princess Ingrid Alexandra, the eldest child, returned home from studying at the University of Sydney to be with her mother, planning to complete her fall semester in Oslo. Additionally, Mette-Marit’s son from a prior relationship, Marius Borg Høiby, was released under house arrest last week. He is currently appealing a four-year prison sentence and is residing at Skaugum, the royal residence, under electronic monitoring. Palace communications indicated that the Crown Prince and Princess wish to assist him during this difficult phase.
The Future of the Monarchy
These simultaneous health challenges have intensified scrutiny on the succession and the longevity of the current regime. King Harald has consistently stated that he will not abdicate. Following Queen Margrethe of Denmark’s decision to step down in 2024, Harald reiterated his commitment to his oath to the Storting. “I stick by what I’ve always said, that I swore an oath to the Storting, and it is for life,” he declared. This stance places the burden of continuity squarely on the Crown Prince and Princess, who must manage their own health issues while maintaining the stability of the institution.
The Royal House has stated it will provide further information as the King’s situation develops, including whether his initial two-week absence will affect the monarchy’s broader program. For now, the focus remains on the bedside of the King, where the quiet presence of the Crown Princess signals a unified front. As Mette-Marit continues her “pretty long road” to recovery, the Norwegian monarchy faces a period of careful management, balancing the health of its leaders with the expectations of a public accustomed to the enduring presence of the King.
